Literature DB >> 33762790

Extensive Cerebral Venous Sinus Thrombosis Due to Medroxyprogesterone Acetate.

Daniel Barmas-Alamdari1, Guneet S Sodhi1, Arielle R Spitze1,2.   

Abstract

This retrospective patient report describes a unique case of cerebral venous sinus thrombosis arising from hormonal contraceptive use, and the management of said thrombosis and its secondary ophthalmic manifestations. The patient initially presented with significant visual decline, headaches, florid disc oedema, and vessel tortuosity, due to extensive sinus thromboses that were causing increased intracranial pressure. It was determined that the root cause of the thrombosis was the use of injectable medroxyprogesterone acetate, leading to a hypercoagulable state. Optic nerve sheath fenestration was performed for this patient as an early intervention. The patient, though ultimately experiencing some vision loss, was able to recover and retain limited unilateral central vision, despite a protracted hospital course. We hope to propose that optic nerve sheath fenestration, in conjunction with anti-coagulation therapy, may be a consideration for patients with similar presentations on an individualised basis, in order to prevent vision loss from cerebral venous sinus thrombosis. Though studies are limited, we believe early intervention may be what allowed our patient to retain some central vision, and suggest more studies be done into the utility of this procedure for patients with this clinical vignette.
© 2020 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Medroxyprogesterone acetate; cerebral venous sinus thrombosis; intracranial hypertension; optic nerve sheath fenestration; papilloedema

Year:  2020        PMID: 33762790      PMCID: PMC7946083          DOI: 10.1080/01658107.2020.1797823

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  5 in total

Review 1.  Optic nerve disorders: role of canal and nerve sheath decompression surgery.

Authors:  J F Acheson
Journal:  Eye (Lond)       Date:  2004-11       Impact factor: 3.775

Review 2.  Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Gustavo Saposnik; Fernando Barinagarrementeria; Robert D Brown; Cheryl D Bushnell; Brett Cucchiara; Mary Cushman; Gabrielle deVeber; Jose M Ferro; Fong Y Tsai
Journal:  Stroke       Date:  2011-02-03       Impact factor: 7.914

Review 3.  [A case of dural sinus thrombosis during the medication of medroxyprogesterone acetate].

Authors:  M Hitosugi; O Kitamura; A Takatsu; K Watanabe; S Kan
Journal:  Nihon Hoigaku Zasshi       Date:  1997-12

4.  The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device.

Authors:  Astrid van Hylckama Vlieg; Frans M Helmerhorst; Frits R Rosendaal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-26       Impact factor: 8.311

5.  Optic nerve sheath fenestration for the treatment of papilledema secondary to cerebral venous thrombosis.

Authors:  Jennifer Murdock; Jonathan H Tzu; Norman J Schatz; Wendy W Lee
Journal:  J Neuroophthalmol       Date:  2014-03       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.